Phio Pharmaceuticals Corp (PHIO NASDAQ) stock market data APIs
$2.1142
0.06(2.8%)
as of September 17, 2025
Try our APIs with
free plan!
Phio Pharmaceuticals Corp Financial Data Overview
Price chart is built with
Anychart
Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts.
Prev. Close
2.1142
Open
2.1743
High
2.1743
Low
2.0726
52 wk Range
0.9657-9.79
Market Cap
12 083 K
Shares Outstanding
5 727 K
EPS
-0.45
Beta
0.889
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Phio Pharmaceuticals Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Phio Pharmaceuticals Corp data using free add-ons & libraries
Get Phio Pharmaceuticals Corp Fundamental Data
Phio Pharmaceuticals Corp Fundamental data includes:
- Net Revenue:
- EBITDA: -7 444 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.36
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Phio Pharmaceuticals Corp News
New
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz
(RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor...
Gapping stocks in Friday's session
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS ...
Phio Pharmaceuticals stock soars after manufacturing agreement
Investing.com -- Phio Pharmaceuticals Corp (NASDAQ:PHIO) stock surged 26% after the company announced it has entered into a drug substance development services agreement with a U.S. manufacturer for i...
Friday's pre-market session: top gainers and losers
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT HTOO [https://www.chartmill.com/stock...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
